- Login ▪ Register
- Message
- Add to favorite
- Website Map
- Select Language
- English
- العربية
- Русский
- India
- Indonesia
- Malay
- ประเทศไทย
- 繁體中文
- 简体中文
- Latest News
- Industry News
[Top] Advances in NanoKnife Ablation for Hilar Cholangiocarcinoma
Recently, Professor Anna from the University of Rome, Italy, conducted a literature review and meta-analysis on the appl..
2024-10-09Detail
[Top] Xu Kecheng‘s Lecture: A Comprehensive Guide to Understanding Breast Diseases
The breast is an important part of the female body, playing a positive role in women’s confidence and mental health. How..
2024-09-24Detail
[Top] Intrahepatic Cholangiocarcinoma: A Challenging Puzzle
Intrahepatic cholangiocarcinoma (ICC) is the second most common type of primary liver cancer after hepatocellular carcin..
2024-09-19Detail
[Top] Eliminating Multiple Tumors at Once! Cryoablation for Multiple Pulmonary Nodules
"Dr. Niu, how many pulmonary nodules were eliminated?" This question was asked by a 30-year-old woman who had three g..
2024-09-03Detail
[Top] Xu Kecheng's Lecture: Quick Guide to the Diagnosis and Treatment of Acute Pancreatitis
In daily life, people who frequently binge eat and drink heavily are prone to developing pancreatitis. Pancreatitis is a..
2024-08-20Detail
[Top] "Electroporation" of Tumors: NanoKnife Emerges as Key Treatment
"This patient weighs 300 pounds and has been suffering from a pancreatic neuroendocrine tumor and recurrent hypoglycemia..
2024-08-06Detail
[Top] Xu Kecheng's Lecture: Targeted Therapy vs. Immunotherapy
In recent years, immunotherapy and targeted therapy have rapidly developed and been widely applied in clinical trials an..
2024-07-30Detail
[Top] Xu Kecheng’s Lecture | Cryoablation Therapy for Renal Cancer
Malignant kidney tumors account for approximately 2%-3% of adult malignancies. In the urinary system, the incidence rate..
2024-07-12Detail
- 1/4
- first
- Previous
- Next
- last